Lindbrook Capital’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $6.74K | Buy |
195
+5
| +3% | +$173 | ﹤0.01% | 1829 |
|
|
2024
Q4 | $5.21K | Sell |
190
-41
| -18% | -$1.13K | ﹤0.01% | 1968 |
|
|
2024
Q3 | $5.88K | Buy |
231
+102
| +79% | +$2.6K | ﹤0.01% | 1950 |
|
|
2024
Q2 | $3.27K | Sell |
129
-367
| -74% | -$9.3K | ﹤0.01% | 2182 |
|
|
2024
Q1 | $15.3K | Buy |
496
+72
| +17% | +$2.23K | ﹤0.01% | 1351 |
|
|
2023
Q4 | $17.1K | Buy |
424
+321
| +312% | +$13K | ﹤0.01% | 1265 |
|
|
2023
Q3 | $2.72K | Hold |
103
| – | – | ﹤0.01% | 2012 |
|
|
2023
Q2 | $1.77K | Hold |
103
| – | – | ﹤0.01% | 2193 |
|
|
2023
Q1 | $1.71K | Buy |
103
+45
| +78% | +$746 | ﹤0.01% | 2306 |
|
|
2022
Q4 | $442 | Sell |
58
-111
| -66% | -$846 | ﹤0.01% | 2617 |
|
|
2022
Q3 | $2K | Buy |
169
+111
| +191% | +$1.31K | ﹤0.01% | 1993 |
|
|
2022
Q2 | $1K | Sell |
58
-453
| -89% | -$7.81K | ﹤0.01% | 2151 |
|
|
2022
Q1 | $5K | Sell |
511
-571
| -53% | -$5.59K | ﹤0.01% | 1570 |
|
|
2021
Q4 | $18K | Buy |
1,082
+1,057
| +4,228% | +$17.6K | ﹤0.01% | 1048 |
|
|
2021
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 1678 |
|
|
2021
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 1556 |
|
|
2021
Q1 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 1514 |
|